GlobalData on MSN3mon
Delcath to trial Hepzato drug device combo in colorectal cancerThe Phase II trial will compare the efficacy and safety of the Hepazo kit when used in combination with the standard of care, ...
John L. Marshall, MD, discusses the impact of the SUNLIGHT trial in patients with refractory metastatic colorectal cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback